Bailard’s Oncternal Therapeutics, Inc. Common Stock ONCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q3
Sell
-4,210
Closed -$93K 783
2022
Q2
$93K Buy
+4,210
New +$93K ﹤0.01% 656